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Abstract. Background: The adverse reaction (AR) to intravenous contrast media (ICM) are 
relatively common. Various opinions pro-posed in the mechanism of the incidence of ICM 
AR. Suspected that the role of Immunoglobulin E (IgE) me-diates allergic conditions that are 
part of the AR. Objective: To determine the difference in total serum IgE level among 
subjects with and without ICM AR on computed tomography (CT) scan examination. To ob-
serve difference in total serum IgE levels in subjects undergoing ICM adverse reaction based 
on the degree of severity. Method: An analytical study with cross-sectional design of 104 
subjects undergoing CT scans with ICM, examined IgE levels before and after ICM was 
administered, then measured the severity of adverse re-actions of contrast media. Result: In 
this study, subjects undergoing adverse reactions, prior to administration Iopamidol had a 
higher mean IgE 1270.79 mg / dl compared with those who having AR 1174.90 mg / dl and 
after administration of Iopamidol a mean of Ig E is still higher in subjects having AR 1507.96 
mg/dl com-pared with those having negative AR that is 1325.88 mg/dl, p = 0.696, 
statistically, not significant. Mild reac-tions in 40 subjects (38.5%) with cough, nausea, 
dizziness, itching, and sweating. Conclusion: Increase in total IgE levels in subjects with 
positive adverse reactions are independent(p=0.696). 
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1. Introduction 
Contrast media iodine is one of the most widely used drugs in the world. This substance was intro-
duced into clinical practice in 1950, and since then about 75 million X-ray examinations have 
been per-formed yearly using contrast media. In addition, the number of patients receiving this 
drug continues to increase with increasing use of CT scans. Although these chemicals are inert 
and are considered relative-ly safe, hypersensitivity reactions may occur to con-trast media 
ranging from mild to severe, even life-threatening [1].  
In radiological imaging, it is usually believed that the adverse reactions of intravenous (IV) 
iodinated con-trast media (ICM) are non-IgE mediated anaphylac-toid reactions, by the result of 
released vasoactive amines (histamine, serotonin, etc.) with the triggering of mast cells directly. 
But exact mechanism is still controversial [2]. The purpose of this study is to de-termine the igE 
levels in the blood in patients under-going CT scan with intravenous contrast, the relation between 
total igE levels and the reactions to contrast media. 
2. Methodology 
Cross sectional studies were conducted from November 2016 to Februari 2017, in RSUP Haji 
Adam Malik Medan, 208 blood samples were taken from 104 subjects between 17-78 years 
(mean,54 years) of age who underwent CT scan procedures with intrave-nous contrast media, in 
this study, used Iopamidol. The exclusion criteria were 1) pregnancy and lactation, 2) patients 
with chronic kidney disease, 3) patients with immunosuppressant for last 48 hours. Blood samples 
were taken from all 104 randomly se-lected patients. First just before administration of IV ICM, 
then at the 48th hours following the exam-ination. Total IgE levels in all the blood samples were 
calculated with VIDAS® by using ELISA method. 
The subjects interviewed and asked about history of atopy in the families by fill in the 
questionnaire. Ear-ly and/or late reactions that were observed during and after administration IV 
ICM were classified as mild, moderate and severe according to Bush and Swanson’s classification 
[3]. The normal value of IgE level was under 100 IU/mL according to the refer-ence value given 
by Dati and Ringel [4]. The result was analyzed by paired t test, chi-square test and t test. 
 
 
3. Results 
During the study, 104 subjects who met the inclusion criteria which 52 subjects were having 
history of atopy. Characteristics of the whole study subjects is presented on (Table 1). 
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Adverse reactions that were observed in 40 (38.5 %) subjects were mild, no moderate and severe 
reac-tions were observed in any patient. Mild adverse reaction was cough 9 subjects (8.6%), 
nausea 10 subjects (9.6%), dizziness 10 subjects (9.6%), itching 10 subjects (9.6%), and sweating 
1 subjects (0.9%) (As shown in fig.1). Observed adverse reactions, were not correlate with total 
igE levels in the blood ac-cording to chi-square test (p= 0.69) (As shown in Table 2). 
Table 1 Characteristics of the Study Subjects 
Characteristics n =104 
Sex  
Male  72 (69,2 %) 
Female  32(30,8%) 
Age , Mean (SD), Years 54,279 (±12,7) 
Atopy history 
Atopi  
Non-atopi   
 
52(50 %) 
52 (50%) 
Ureum, median (min-max), 
mg/dL 
24 (9-86) 
Creatinin, median (min-max), 
mg/dL 
0.78 (0.13 – 1.77) 
Ig E pre-CT scan, median 
(min-max), U/L 
518,700 (10 –8693,0) 
Ig E post CT scan, median 
(min-max), U/L 
721,500 (25,0 – 9458,0) 
 
Adverse reactions that were observed in 40 (38.5 %) subjects were mild, no moderate and severe 
reactions were observed in any patient. Mild adverse reaction was cough 9 subjects (8.6%), nausea 
10 subjects (9.6%), dizziness 10 subjects (9.6%), itching 10 sub-jects (9.6%), and sweating 1 
subjects (0.9%). (As shown in Fig.1) Observed adverse reactions, were not correlate with total 
igE levels in the blood ac-cording to chi-square test (p= 0.69). (As shown in Table 2). 
Table 2 Mean and Median of Total Serum Ige Level in Subjects with and without 
Adverse 
Adverse 
reactions 
(AR) 
                          Total Serum IgE Level 
Pre-CT scan Post CT scan P 
 Mean Std. 
Deviatio
n 
Mean Std. 
Deviati
on 
Without 
AR 
(n=64) 
1159.85
0 
1479.349
3 
1308.93
3 
1670.86
56 
0,69
6 
With AR 
(n=40) 
1270.78
5 
1787.465
4 
1507.95
5 
2052.36
53 
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Figure 1 Observed Adverse Reactions in Subjects of the Study 
 
 
Table 3 Adverse Reaction in Subjects with Atopy and Non-Atopy After  
 Administration IV ICM 
Subjects Adverse reaction (AR) Total  p 
Without 
AR 
With AR 
Atopy  30 (58%) 22 (42%) 52 (100%) 0.110* 
Non-atopy 34 (65%) 18 (35%) 52 (100%) 
Total  64 (61,5%) 40 
(38,5%) 
104 
(100%) 
 
        *Chi square test 
From Table 3, shown observed AR in 42% atopy subjects, and 35% in non-atopy subjects. With 
Chi-square, p= 0.110 showed no significantly difference on atopy with non-atopy in the 
observed adverse reaction after IV ICM. 
4. Discussion 
The results of this study shows the characteristics of the study subjects with positive adverse 
reactions were mostly male, 28 subjects (70%); this is different from the findings of Dundee and 
colleagues who conducted research on atopy and allergy in 10,000 patients undergoing anesthesia, 
the results obtained, found an allergy in iodine with 0.8% in men and 1.4% in women. One of the 
causes of this difference that can be stated is the amount of sample differ-ence, where the number 
of samples with male sex dominates 72 people (69.2%) of the total sample population [5]. 
Positive adverse reaction was found in atopy pa-tients by 42% compared with incidence in non-
atopy patients of 35%. This is in line with the results of a study conducted by Dundee and 
colleagues who obtained similar results, which encountered higher frequency of adverse reactions 
in patients with a history of atopy of 36.2% compared with patients who did not have a history of 
atopy of 11, 4% [5]. 
This study obtained an adverse reaction found only mild symptom reactions of 38.5% in contrast 
to findings of Wang et al who found, from 84,928 observed patients, who underwent iodine 
contrast CT scans, found 545 adverse reactions (0.6%) whereby of the total adverse reactions 
occurring 418 cases (77%) of which were mild reactions and 116 cases (21%) were moderate 
reactions, and the remaining 11 (2%) cases were severe reactions requiring treat-ment. In the 
meantime, Gurses and Guler found that of 88 patients who underwent intravenous contrast CT 
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scans found 13 patients (14.7%) with mild and moderate reactions, but did not specify how large 
each reaction was. The reasons that can be stated from the differences of the research findings 
above are the demographic differences, as well as the dif-ferent types of contrast media used [6]. 
The results of this study shows that the subjects of the study experienced a positive crossover 
reac-tion, before contrast administration Iopamidol had a higher mean IgE level of 1270.79 mg / 
dl compared with those not having an adverse reaction ie, 1174.90 mg / dl and after contrast 
administration Io-pamidol has a higher mean Ig E levels of 1507.96 mg / dl compared with those 
not experiencing an ad-verse reaction of 1325.88 mg / dl. This is in line with a study by Gurses 
and Guler, which suggests that initial baseline igE measurements as baseline cannot be a 
prognostic factor for adverse reactions, however, adverse reactions that occur can be found at 
higher IgE levels after contrast. In this study found in respondents with positive adverse reaction, 
found increased serum IgE-levels greater than respondents who did not undergo adverse reactions 
[6]. 
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